Page 65 - TI Journal 18-1
P. 65
USE OF PiB FOR PET IMAGING OF AD 59
39. Nelissen, N.; Vandenbulcke, M.; Fannes, K.; Hoge, J. A.; Ziolko, S. K.; Holt, D. P.; Meltzer, C.
Verbruggen, A.; Peeters, R.; Dupont, P.; Van C.; Dekosky, S. T.; Mathis, C. A. Kinetic mod-
Laere, K.; Bormans, G.; Vandenberghe, R. Abeta eling of amyloid binding in humans using PET
amyloid deposition in the language system and imaging and Pittsburgh Compound-B. J. Cereb.
how the brain responds. Brain 130(Pt 8):2055- Blood Flow Metab. 25:1528–1547; 2005.
2069; 2007. 45. Price, J. C.; Ziolko, S. K.; Weissfeld, L. A.; Klunk,
40. Nilsberth, C.; Westlind-Danielsson, A.; Eckman, W. E.; Lopresti, B. J.; Hoge, J. A.; Lu, X. L.; Bi, W.
C. B.; Condron, M. M.; Axelman, K.; Forsell, C.; Z.; Meltzer, C. C.; Tsopelas, N; DeKosky, S.T.;
Stenh, C.; Luthman, J.; Teplow, D. B.; Younkin, Mathis, C.A. FDG and PIBPET imaging in
S. G.; Näslund, J.; Lannfelt, L. The ‘Arctic’ APP Alzheimer’s disease and mild cognitive impair-
mutation (E693G) causes Alzheimer’s disease ment. Neuropsychopharmacology 30:S225-S225;
by enhanced Abeta protofibril formation. Nat. 2005.
Neurosci. 4(9):887-893; 2001. 46. Reiman, E. M.; Chen, K.; Liu, X.; Bandy, D.; Yu,
41. Ossenkoppele, R.; Jansen, W. J.; Rabinovici, G. M.; Lee, W.; Ayutyanont, N.; Keppler, J.; Reeder,
D.; Knol, D. L.; van der Flier, W. M.; van Berckel, S. A.; Langbaum, J. B. S.; Alexander, G.E.; Klunk,
B. N.; Scheltens, P.; Visser, P. J.; Amyloid, P. E. T. W.E.; Mathis, C.A.; Price, J.C.; Aizenstein, H.J.;
S. G.; Verfaillie, S. C.; Zwan, M.D.; Adriaanse, DeKosky, S.T.; Caselli, R.J. Fibrillar amyloid-beta
S.M.; Lammertsma, A.A.; Barkhof, F.; Jagust, burden in cognitively normal people at 3 levels
W.J.; Miller, B.L.; Rosen, H.J.; Landau, S.M.; of genetic risk for Alzheimer’s disease. Proc. Natl.
Villemagne, V.L.; Rowe, C.C.; Lee, D.Y.; Na, Acad. Sci. U.S.A. 106(16):6820-6825; 2009.
D.L.; Seo, S.W.; Sarazin, M.; Roe, C.M.; Sabri, 47. Remes, A. M.; Finnila, S.; Mononen, H.;
O.; Barthel, H.; Koglin, N.; Hodges, J.; Leyton, Tuominen, H.; Takalo, R.; Herva, R.; Majamaa,
C.E.; Vandenberghe, R.; van Laere, K.; Drzezga, K. Hereditary dementia with intracerebral
A.; Forster, S.; Grimmer, T.; Sánchez-Juan, P.; hemorrhages and cerebral amyloid angiopathy.
Carril, J.M.; Mok, V.; Camus, V.; Klunk, W.E.; Neurology 63(2):234-240; 2004.
Cohen, A.D.; Meyer, P.T.; Hellwig, S.; Newberg, 48. Remes, A. M.; Laru, L.; Tuominen, H.; Aalto,
A.; Frderiksen, K.S.; Fleisher, A.S.; Mintun, M.A.; S.; Kemppainen, N.; Mononen, H.; Någen, K.;
Wolk, D.A.; Nordberg, A.; Rinne, J.O.; Chételat, Parkkola, R.; Rinne, J. O. 11C-PIB-PET amyloid
G.; Lleo, A.; Blesa, R.; Fortea, J.; Madsen, K.; imaging in patients with APP locus duplication.
Rodrigue, K.M.; Brooks, D.J. Prevalence of amy- Arch. Neurol. 65(4):540-544; 2007.
loid PET positivity in dementia syndromes: a 49. Resnick, S. M.; Sojkova, J. Amyloid imaging
meta-analysis. JAMA 313(19):1939-1949; 2015. and memory change for prediction of cognitive
42. Petersen, R. C.; Wiste, H. J.; Weigand, S. D.; Rocca, impairment. Alzheimers Res. Ther. 3(1):3; 2011.
W. A.; Roberts, R. O.; Mielke, M. M.; Lowe, V. J.; 50. Rovelet-Lecrux, A.; Frebourg, T.; Tuominen,
Knopman, D. S.; Pankratz, V. S.; Machulda, M. H.; Majamaa, K.; Campion, D.; Remes, A. M.
M.. Association of elevated amyloid levels with APP locus duplication in a Finnish family with
cognition and biomarkers in cognitively nor- dementia and intracerebral haemorrhage. J.
mal people from the community. JAMA Neurol. Neurol. Neurosurg. Psychiatry 78(10):1158-
73(1):85-92; 2016. 1159; 2007.
43. Pike, K. E.; Savage, G.; Villemagne, V. L.; Ng, 51. Rowe, C. C.; Ellis, K. A.; Rimajova, M.; Bourgeat,
S.; Moss, S. A.; Maruff, P.; Mathis, C. A.; Klunk, P.; Pike, K. E.; Jones, G.; Fripp, J.; Tochon-Danguy,
W. E.; Masters, C. L.; Rowe, C. C. Beta-amyloid H.; Morandeau, L.; O’Keefe, G.; Price, R.; Raniga,
imaging and memory in non-demented individ- P.; Robins, P.; Acosta, O.; Lenzo, N.; Szoeke, C.;
uals: evidence for preclinical Alzheimer’s disease. Salvado, O.; Head, R.; Martins, R.; Masters, C.L.;
Brain 130(Pt 11):2837-2844; 2007. Ames, D.; Villemagne, V.L. Amyloid imaging
44. Price, J. C.; Klunk, W. E.; Lopresti, B. J.; Lu, X.; results from the Australian Imaging, Biomarkers

